Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

Abroad (travel likely)RecruitingPHASE3

Conditions

Focal Seizure · Epilepsy · Focal Epilepsy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Pillar Clinical Research, Bentonville, Arkansas, United States
Colorado Springs Neurological Associates, Colorado Springs, Colorado, United States
K2 Medical Research, Maitland, Florida, United States

Study leads

Vicente Villaneuva, M.D., PhD
Principal Investigator
Hospital Universitari i Politecnic La Fe, Spain

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

Focal Seizure · Epilepsy · Focal Epilepsy

Abroad (travel likely)RecruitingPHASE3

Palmdale, United States · Fort Wayne, United States

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Focal Epilepsy · Epilepsy · Refractory Focal Epilepsy

Abroad (travel likely)RecruitingPHASE2

Boise, United States · Rochester, United States

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

Drug Resistant Epilepsy · Epilepsy · Seizures, Focal

Abroad (travel likely)RecruitingPHASE1, PHASE2

Palo Alto, United States · Boston, United States

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Focal Epilepsy

Abroad (travel likely)RecruitingPHASE2, PHASE3

Phoenix, United States · Tucson, United States